Renal phosphate loss in Iraqi chronic myeloid leukemia patients treated by imatinib mesylate
BACKGROUND: The use of BCR-ABL tyrosine kinase inhibitor imatinib mesylate improved outcomes for patients with chronic myeloid leukemia (CML). Hypophosphatemia is found to be associated with imatinib mesylate use; the exact mechanism of this is not clear yet but mostly related to a drug-induced prox...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2020-01-01
|
| coleção: | Iraqi Journal of Hematology |
| Assuntos: | |
| Acesso em linha: | http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=72;epage=76;aulast=Al-Taee |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|